Developing Gene-Based Therapeutics

Strategic considerations for regulatory, operational, and commercial success

Michael Murphy, MD, PhD

Worldwide’s experts discuss the regulatory, operational, and commercial considerations for gene therapy development.

Your form has been successfully submitted! Click the button below to access.
Read more
Michael Murphy, MD, PhD
Meet the author

Michael Murphy, MD, PhD

Chief Medical and Scientific Officer
Learn more